Destacados de IA Evidencia pública, comprobada sept 2026
Producto Magellan is Gain’s platform technology that leverages AI-supported structural biology, proprietary algorithms and physics-based models powered by the cutting-edge CSCS Swiss National Supercomputing Centre to explore novel allosteric binding pockets on disease-implicating proteins.. Describes its own product as AI on its own site: "ai" sept 2026 ↗ Producto Combining physics-based methods with artificial intelligence, Gain is developing best-in-class small molecules for disorders with high unmet medical need. Describes its own product as AI on its own site: "artificial intelligence" sept 2026 ↗ Producto Magellan’s unique machine learning AI models evaluate the 3D structures of proteins and potential allosteric sites.. Names the technique "machine learning", on its own site sept 2026 ↗